Gil Blum Score: 17
Analyst at
Needham
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
-17.7%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
24%
5 W / 16 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
36%
5 W / 9 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
7%
1 W / 13 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 14 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
22%
4 W / 14 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
24%
5 W / 16 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 |
Rocket Pharmaceuticals Inc
RCKT
|
BUY |
$9.00
Est. +164%
|
$3.41 | $3.76 |
Pending
|
$2.20
-35.5%
|
| Aug 21, 2026 |
Faeth Therapeutics, Inc.
FTH
|
BUY |
$56.00
Est. +74%
|
$32.10 | $27.03 |
Pending
|
$20.57
-35.9%
|
| Aug 14, 2026 |
Celcuity Inc
CELC
|
BUY |
$140.00
Est. +62%
|
$86.60 | $97.82 |
Pending
|
$61.56
-28.9%
|
| Mar 10, 2026 |
Celcuity Inc
CELC
|
BUY |
$122.00
Est. +5%
|
$115.94 | $151.02 |
Target Met
|
$61.56
-46.9%
|
| Dec 04, 2025 |
Solid Biosciences Inc
SLDB
|
BUY |
$16.00
Est. +208%
|
$5.19 | $11.44 |
Pending
|
$6.41
+23.5%
|
| Oct 02, 2025 |
Taysha Gene Therapies Inc
TSHA
|
BUY |
$10.00
Est. +110%
|
$4.77 | $7.30 |
Miss
|
$4.12
-13.6%
|
| Jul 10, 2025 |
Mereo Biopharma Group Plc - ADR
MREO
|
BUY |
$5.00
Est. +167%
|
$1.87 | $2.37 |
Miss
|
$0.29
-84.4%
|
| Nov 27, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$202.00
Est. +48%
|
$136.87 | $138.69 |
Miss
|
$18.56
-86.4%
|
| Sep 04, 2024 |
Recursion Pharmaceuticals Inc - Ordinary Shares - Class A
RXRX
|
BUY |
$11.00
Est. +80%
|
$6.10 | $12.36 |
Target Met
|
$3.64
-40.3%
|
| Aug 13, 2024 |
Artiva Biotherapeutics Inc
ARTV
|
BUY |
$23.00
Est. +105%
|
$11.22 | $17.31 |
Miss
|
$6.49
-42.2%
|
| Aug 06, 2024 |
CRISPR Therapeutics AG
CRSP
|
BUY |
$84.00
Est. +68%
|
$50.11 | $71.13 |
Miss
|
$50.50
+0.8%
|
| Jun 25, 2024 |
G1 Therapeutics Inc
GTHX
|
BUY |
$6.00
Est. +170%
|
$2.22 | $7.19 |
Target Met
|
$7.16
+222.5%
|
| Jun 12, 2024 |
Mereo Biopharma Group Plc - ADR
MREO
|
BUY |
$7.00
Est. +99%
|
$3.52 | $5.02 |
Miss
|
$0.29
-91.7%
|
| Mar 28, 2024 |
Celcuity Inc
CELC
|
BUY |
$24.00
Est. +32%
|
$18.16 | $19.77 |
Miss
|
$61.56
+239.0%
|
| Mar 28, 2024 |
Mereo Biopharma Group Plc - ADR
MREO
|
BUY |
$6.00
Est. +100%
|
$3.00 | $5.02 |
Miss
|
$0.29
-90.3%
|
| Mar 22, 2024 |
Nkarta Inc
NKTX
|
BUY |
$15.00
Est. +16%
|
$12.98 | $8.23 |
Miss
|
$1.75
-86.5%
|
| Mar 18, 2024 |
Arcellx Inc
ACLX
|
BUY |
$81.00
Est. +17%
|
$69.11 | $107.37 |
Target Met
|
$115.07
+66.5%
|
| Mar 15, 2024 |
Geron Corp.
GERN
|
BUY |
$5.00
Est. +49%
|
$3.36 | $5.06 |
Precision Hit (±3%)
|
$1.16
-65.5%
|
| Nov 03, 2022 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$158.00
Est. +50%
|
$105.01 | - | - |
$18.56
-82.3%
|
| Mar 02, 2022 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$150.00
Est. +89%
|
$79.56 | - | - |
$18.56
-76.7%
|
| Feb 16, 2022 |
CRISPR Therapeutics AG
CRSP
|
BUY |
$170.00
Est. +174%
|
$61.97 | - | - |
$50.50
-18.5%
|
Rocket Pharmaceuticals Inc
RCKT
Sep 16, 2026
Signal & Target
BUY
$9.00
Start Price
$3.41
Best Price (1Y)
$3.76
Current Price
$2.20
Return
-35.5%
Faeth Therapeutics, Inc.
FTH
Aug 21, 2026
Signal & Target
BUY
$56.00
Start Price
$32.10
Best Price (1Y)
$27.03
Current Price
$20.57
Return
-35.9%
Celcuity Inc
CELC
Aug 14, 2026
Signal & Target
BUY
$140.00
Start Price
$86.60
Best Price (1Y)
$97.82
Current Price
$61.56
Return
-28.9%
Celcuity Inc
CELC
Mar 10, 2026
Signal & Target
BUY
$122.00
Start Price
$115.94
Best Price (1Y)
$151.02
Current Price
$61.56
Return
-46.9%
Solid Biosciences Inc
SLDB
Dec 04, 2025
Signal & Target
BUY
$16.00
Start Price
$5.19
Best Price (1Y)
$11.44
Current Price
$6.41
Return
+23.5%
Taysha Gene Therapies Inc
TSHA
Oct 02, 2025
Signal & Target
BUY
$10.00
Start Price
$4.77
Best Price (1Y)
$7.30
Current Price
$4.12
Return
-13.6%
Mereo Biopharma Group Plc - ADR
MREO
Jul 10, 2025
Signal & Target
BUY
$5.00
Start Price
$1.87
Best Price (1Y)
$2.37
Current Price
$0.29
Return
-84.4%
Sarepta Therapeutics Inc
SRPT
Nov 27, 2024
Signal & Target
BUY
$202.00
Start Price
$136.87
Best Price (1Y)
$138.69
Current Price
$18.56
Return
-86.4%
Signal & Target
BUY
$11.00
Start Price
$6.10
Best Price (1Y)
$12.36
Current Price
$3.64
Return
-40.3%
Artiva Biotherapeutics Inc
ARTV
Aug 13, 2024
Signal & Target
BUY
$23.00
Start Price
$11.22
Best Price (1Y)
$17.31
Current Price
$6.49
Return
-42.2%
CRISPR Therapeutics AG
CRSP
Aug 06, 2024
Signal & Target
BUY
$84.00
Start Price
$50.11
Best Price (1Y)
$71.13
Current Price
$50.50
Return
+0.8%
G1 Therapeutics Inc
GTHX
Jun 25, 2024
Signal & Target
BUY
$6.00
Start Price
$2.22
Best Price (1Y)
$7.19
Current Price
$7.16
Return
+222.5%
Mereo Biopharma Group Plc - ADR
MREO
Jun 12, 2024
Signal & Target
BUY
$7.00
Start Price
$3.52
Best Price (1Y)
$5.02
Current Price
$0.29
Return
-91.7%
Celcuity Inc
CELC
Mar 28, 2024
Signal & Target
BUY
$24.00
Start Price
$18.16
Best Price (1Y)
$19.77
Current Price
$61.56
Return
+239.0%
Mereo Biopharma Group Plc - ADR
MREO
Mar 28, 2024
Signal & Target
BUY
$6.00
Start Price
$3.00
Best Price (1Y)
$5.02
Current Price
$0.29
Return
-90.3%
Nkarta Inc
NKTX
Mar 22, 2024
Signal & Target
BUY
$15.00
Start Price
$12.98
Best Price (1Y)
$8.23
Current Price
$1.75
Return
-86.5%
Arcellx Inc
ACLX
Mar 18, 2024
Signal & Target
BUY
$81.00
Start Price
$69.11
Best Price (1Y)
$107.37
Current Price
$115.07
Return
+66.5%
Geron Corp.
GERN
Mar 15, 2024
Signal & Target
BUY
$5.00
Start Price
$3.36
Best Price (1Y)
$5.06
Current Price
$1.16
Return
-65.5%
Sarepta Therapeutics Inc
SRPT
Nov 03, 2022
Signal & Target
BUY
$158.00
Start Price
$105.01
Best Price (1Y)
-
Current Price
$18.56
Return
-82.3%
Sarepta Therapeutics Inc
SRPT
Mar 02, 2022
Signal & Target
BUY
$150.00
Start Price
$79.56
Best Price (1Y)
-
Current Price
$18.56
Return
-76.7%
CRISPR Therapeutics AG
CRSP
Feb 16, 2022
Signal & Target
BUY
$170.00
Start Price
$61.97
Best Price (1Y)
-
Current Price
$50.50
Return
-18.5%